Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Vivos Therapeutics (VVOS) Debt to Equity (2019 - 2025)

Vivos Therapeutics' Debt to Equity history spans 4 years, with the latest figure at -$5.92 for Q4 2025.

  • Quarterly results put Debt to Equity at -$5.92 for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was -$5.92 (changed N/A YoY), and the annual figure for FY2025 was -$5.92, changed.
  • Debt to Equity for Q4 2025 was -$5.92 at Vivos Therapeutics, down from $3.44 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $3.44 in Q3 2025 to a low of -$5.92 in Q4 2025.